Search by Drug Name or NDC

    NDC 24338-0230-12 Nymalize 30 mg/5mL Details

    Nymalize 30 mg/5mL

    Nymalize is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is NIMODIPINE.

    Product Information

    NDC 24338-0230
    Product ID 24338-230_8c3aba10-0b86-4b03-8952-adc2a2b950b4
    Associated GPIs 34000022002054
    GCN Sequence Number 080991
    GCN Sequence Number Description nimodipine SYRINGE 30 MG/5 ML ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 47984
    HICL Sequence Number 000184
    HICL Sequence Number Description NIMODIPINE
    Brand/Generic Brand
    Proprietary Name Nymalize
    Proprietary Name Suffix n/a
    Non-Proprietary Name nimodipine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/5mL
    Substance Name NIMODIPINE
    Labeler Name Azurity Pharmaceuticals, Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203340
    Listing Certified Through 2024-12-31

    Package

    NDC 24338-0230-12 (24338023012)

    NDC Package Code 24338-230-12
    Billing NDC 24338023012
    Package 12 PACKAGE in 1 CARTON (24338-230-12) / 1 SYRINGE, PLASTIC in 1 PACKAGE (24338-230-05) / 5 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2020-05-04
    NDC Exclude Flag N
    Pricing Information N/A